ME Therapeutics Holdings Inc. (CSE:METX)
Canada flag Canada · Delayed Price · Currency is CAD
9.00
0.00 (0.00%)
Apr 17, 2025, 4:00 PM EDT

ME Therapeutics Holdings Cash Flow Statement

Millions CAD. Fiscal year is Sep - Aug.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Feb '25 Aug '24 Aug '23 Aug '22
Net Income
-1.31-1.29-6.52-0.15
Depreciation & Amortization
0.03000
Stock-Based Compensation
0.650.70.620.01
Other Operating Activities
0.01-5.550.01
Change in Accounts Payable
0.01-0.060.06-0
Change in Other Net Operating Assets
-0.03-0-0.02-0.01
Operating Cash Flow
-0.65-0.66-0.3-0.14
Cash Acquisitions
--0.76-
Investing Cash Flow
-0.17-0.76-
Short-Term Debt Issued
---0.14
Total Debt Issued
---0.14
Short-Term Debt Repaid
--0.04--
Total Debt Repaid
-0.02-0.04--
Net Debt Issued (Repaid)
-0.02-0.04-0.14
Issuance of Common Stock
1.51.560.12-
Other Financing Activities
-0.01-0.01--
Financing Cash Flow
1.471.510.120.14
Net Cash Flow
0.650.850.570
Levered Free Cash Flow
--0.220.07-
Unlevered Free Cash Flow
--0.220.08-
Change in Net Working Capital
-0.06-0.07-
Updated Jan 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.